Lack of clinically relevant differences in safety and pharmacokinetics after second‐dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis-Reference-Cited by-同舟云学术

Lack of clinically relevant differences in safety and pharmacokinetics after second‐dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis

Published:2022-04-19 Issue:7 Volume:63 Page:1714-1723
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Cascino Gregory D.¹^ORCID,Tarquinio Daniel²,Wheless James W.³^ORCID,Hogan Robert Edward⁴^ORCID,Sperling Michael R.⁵^ORCID,Desai Jay⁶,Vazquez Blanca⁷,Samara Emil⁸,Misra Sunita N.⁹^ORCID,Carrazana Enrique⁹¹⁰^ORCID,Rabinowicz Adrian L.⁹^ORCID,

Affiliation:

1. Mayo Clinic Rochester Minnesota USA

2. Center for Rare Neurological Diseases Atlanta Georgia USA

3. Le Bonheur Children’s Hospital University of Tennessee Health Science Center Memphis Tennessee USA

4. Washington University in St Louis St Louis Missouri USA

5. Thomas Jefferson University Philadelphia Pennsylvania USA

6. Children’s Hospital of Los Angeles California USA

7. Comprehensive Epilepsy Center New York University New York New York USA

8. PharmaPolaris International Washington District of Columbia USA

9. Neurelis San Diego California USA

10. John A. Burns School of Medicine University of Hawaii Honolulu Hawaii USA

Publisher